Secretary Krebs, what is the standard applied to agencies working to successfully remove all Kaspersky products from the...
do you plan to consult with this Committee on the directive's progress after the initial 60-day review?
I have serious concerns about the attention that we are paying to these kinds of issues.
I share the frustration that you are hearing from everyone on this committee about decisions that have not been made act...
I am pleased that finally we have seen the administration act on that.
Kaspersky Lab has reported links to Russian intelligence, and it is based in Moscow, subjects client data to the Kremlin...
So what standards were used in approving Kaspersky Lab as an appropriate choice to fill the U.S. Government's antivirus ...
If we were to establish service levels for getting back to people and resolving issues, that would be a big first step i...
Two years of inaction on this front is not going to get the job done.
the frustration of processing benefits or background investigations or even retirement is unacceptable.
I really appreciate how hard people are working at OPM and how hard our civil servants work when they are processing the...
Too often, Federal workforce is viewed as a cost, not as an asset, and training dollars are among the first to go.
Thank you very much, Mr. Chair, and to our Ranking Member as well.
Thank you, Mr. Chairman. I will tell you, this issue is very personal to me.
the patient should always pay the lowest cost-sharing possible for a given drug.
To exploit tribal sovereign immunity to avoid competition as opposed to dealing with the patent system, in my view, is u...
Allergan's behavior here is unacceptable, and if other drug companies follow its lead, the problem is only going to get ...
I hear from granite staters all the time who struggle to afford their medications, and they are so frustrated.
